22-Feb-2007 - Johnson Matthey's metal scavenging system, Smopex, is designed to remove precious metals at high speed from solutions and active pharmaceutical ingredients (APIs).
20-Feb-2007 - Biotechnology firm Codexis has launched its Codex biocatalyst panels, which promise to increase R&D and manufacturing productivity while reducing cost.
20-Feb-2007 - Israeli-based Chemada has announced that heavy brines can be used as solvent in pharmaceutical applications to cut waste and costs. The company made the announcement at last week's InformexUSA show in San Francisco.
15-Feb-2007 - Materia's metathesis platform continues to excite the pharmaceutical industry as they follow their recent license to Merck with a license to Aileron Therapeutics.
07-Feb-2007 - UK-based firm BioProgress has developed novel tablet cores that mean pills which were previously very difficult to coat can be reformulated and easily coated using the company's innovative TabWrap technology.
06-Feb-2007 - US Food and Drug Administration (FDA) has until April 2007 to reply to a Citizen's Petition (CP) filed by Orchid Chemicals in response to accusations of 'evergreening' related to Wyeth's re-formulated Zosyn (piperacillin/tazobactam), an injectable antibacterial drug.
06-Feb-2007 - US Democrats spearheaded by Henry Waxman intend to re-table a stalled piece of legislation that would allow US Food and Drug Administration (FDA) approval of generic biodrugs, which they claim would result in cost savings for patients and healthcare payers.
02-Feb-2007 - Pfizer's latest cutbacks will provide a new outsourcing opportunity for contract manufacturing organisations (CMOs) in low-cost destinations as the drug giant announces plans to double its amount of drug production outsourcing.
01-Feb-2007 - MorphoSys has just opened new UK headquarters for its antibody-focused business unit, giving the company expanded capacity for its antibody production - a rapidly growing market in the UK.
31-Jan-2007 - A team of researchers in the UK have come up with a novel drug delivery system using pollen-based microcapsules to encapsulate the active ingredients, opening up whole new avenues for oral delivery of injection-based drugs.
31-Jan-2007 - Microbiology specialists Oxoid have added a new growth medium product to their catalogue of microbiological culture media, for use in aseptic process simulations.
22-Jan-2007 - New French research into biodegradable polymers is opening up the door to controlled release treatments for a broader range of drugs, potentially doing away with traditional delivery methods of a variety of drugs.
18-Jan-2007 - A new player has entered the pharma formulation development services arena, offering technologies used in the food industry to improve drug palatability.
16-Jan-2007 - Russian researchers have developed a new way of sourcing a widely used cardiovascular drug using an ecologically friendly and water-based extraction method, which could yield three-fold cost savings over conventional approaches.
15-Jan-2007 - Canadian firm SemBioSys Genetics last week announced that its proprietary plant-produced insulin has been shown to be indistinguishable from human insulin, opening up a whole new potential source of the hormone.
10-Jan-2007 - 2007 will be a tough year for pharmaceutical employers as the industry struggles to find enough staff with specialised technical skills and industry experience, says new research.
08-Jan-2007 - The US Food and Drug Administration (FDA) has approved Janssen's new drug Invega (paliperidone); the first new prescription drug for the treatment of schizophrenia since 2003.
04-Jan-2007 - Philanthropic researchers in the UK have developed a brand new drug for Hepatitis C that dodges restrictive patents held by pharma heavyweights.
19-Dec-2006 - Introgen Therapeutics last week announced that it has been granted a European patent for the commercial production of adenoviral compositions.
18-Dec-2006 - The directed evolution of enzymes can lead to more efficient tools for the synthesis of drug molecules.
18-Dec-2006 - The once hyped antisense sector of the pharmaceutical industry has again proved a disappointment after one drug in development was refused approval and another was scrapped.
18-Dec-2006 - Dr Reddy's Laboratories has boosted its ability to serve Western pharmaceutical markets with an increase in its manufacturing capacity for drug formulations.
13-Dec-2006 - Roche has invested $20m in a new technology that has the potential to dramatically enhance the delivery of subcutaneous drugs by acting like a 'molecular machete'.
13-Dec-2006 - Pharmaceutical giant AstraZeneca has invested in a tablet manufacturing plant in Egypt, which could form a launching pad for an expansion into emerging markets.
12-Dec-2006 - Almost 130 jobs will be lost at BASF's Minden site as the company succumbs to growing pressure from the Asian generic active pharmaceutical ingredient (API) market.